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Sir, We have read with great interest the article by Wu and Hallett
(2013) entitled ‘The cerebellum in Parkinson’s disease’. These au-
thors reviewed related anatomical, clinical and neurophysiological
findings, and discuss the possible roles of the cerebellum in the
pathophysiology of Parkinson’s disease. They pointed out that
Parkinson’s disease is associated with pathological and structural
changes in the cerebellum, and also stated that functional neuroi-
maging has demonstrated increased activation of the cerebellum
in Parkinson’s disease. Furthermore, tremor and cerebellar involve-
ment is discussed in Parkinson’s disease, and a primary dysfunction
in the cerebello-thalamo-cortical circuit, particularly the vermis/
paravermis region, is thought to be responsible for the occurrence
of resting tremor. Another assumption is that functional or struc-
tural changes in the cerebellum may contribute to non-motor
symptoms in Parkinson’s disease. The authors propose that the
major role of the cerebellum in Parkinson’s disease includes patho-
logical and compensatory effects, and that pathological changes in
the cerebellum might be induced by dopaminergic degeneration
(Wu and Hallet, 2013).
Spinocerebellar ataxias (SCA) are defined as a group of auto-
somal dominant ataxic disorders caused by degeneration of the
cerebellum and its afferent and efferent connections (Scho¨ls
et al., 2004). Besides ataxia, SCA have a wide range of neuro-
logical symptoms including extrapyramidal signs, such as parkin-
sonism. The most common SCA worldwide is spinocerebellar
ataxia type 3 (SCA3) or Machado-Joseph disease (Pedroso
et al., 2012). Interestingly, a specific phenotype of SCA3 classically
described in patients of African origin, is comprised by pure par-
kinsonism without ataxia. Also, parkinsonism, especially the akin-
etic-rigid syndrome, has been described in patients with SCA,
particularly SCA2, SCA3 and SCA17, and is a common condition
in Asian patients (Scho¨ls et al., 2000; Schmitz-Hu¨bsch et al.,
2008). In a Brazilian series of 104 patients with Machado-Joseph
disease, parkinsonism was seen in eight cases and there was no
relationship with CAG repeat size or age of symptom onset. It
should be noted that levodopa is an effective treatment in this
group of patients with SCA3 (Teive et al., 2012). But what is
the reason for the presence of parkinsonism in SCA?
Considering pathological studies in SCA3, atrophy of the pons,
basal ganglia, midbrain, medulla oblongata, multiple cranial nerve
nuclei, thalamus, and the frontal, parietal, temporal, occipital and
limbic lobes have been observed (Rub et al., 2008). Of note, de-
generation of the substantia nigra is not an unusual pathological
finding (Fig. 1). As for neuroimaging features, hyperechogenicity
of the substantia nigra has been observed through transcranial
sonography in patients with SCA3, similarly to Parkinson’s disease,
although no correlation between echogenicity and parkinsonian
features has been found (Pedroso et al., 2011). In addition,
single-photon emission computed tomography (SPECT) with
99mTc-TRODAT-1, a dopamine transporter (DAT) radiotracer re-
stricted to the striatum, discloses significant reductions of dopa-
mine transporter density in the caudate and putamen of patients
with SCA3, as well as in Parkinson’s disease (Braga-Neto et al.,
2012). Anatomical and biochemical findings have previously sug-
gested the existence of connections between the cerebellum and
basal ganglia and more recent studies have shown that the cere-
bellum influences glutamatergic and dopaminergic striatal activity
(Delis et al., 2013). This is in line with Wu and Hallett (2013),
when they presumed that pathological changes in the cerebellum
might be induced by dopaminergic degeneration; perhaps
doi:10.1093/brain/awt089 Brain 2013: 136; 1–2 | e248
. Advance Access publication June 4, 2013
 The Author (2013). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved.
For Permissions, please email: journals.permissions@oup.com






parkinsonism in primary cerebellar disorders is related to cerebello-
thalamo-cortical circuit involvement and basal ganglia impairment.
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Figure 1 (A) Pathological study of a previous healthy subject with normal dopaminergic neurons in the substantia nigra. (B) Patient with
SCA3 in advanced stage, with degeneration of the substantia nigra in the midbrain. This patient had parkinsonism characterized by
bradykinesia and postural instability. Note thinner and sparse cells of the substantia nigra in (B), when compared with (A).
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